2008
DOI: 10.1007/s00431-008-0755-5
|View full text |Cite
|
Sign up to set email alerts
|

Does diagnostic delay result in decreased survival in paediatric brain tumours?

Abstract: To study the hypothesis that a delay in the diagnosis of paediatric brain tumours results in decreased survival outcome probability, we compared the prediagnostic period of 315 brain tumour patients (median age 6.7 years, range, 0 to 16 years) with progression-free and overall survival. The median prediagnostic symptomatic interval was 60 days (range, 0 to 3,480 days), with a median parental delay of 14 days (range, 0 to 1,835 days) and a median doctor's delay of 14 days (range, 0 to 3,480 days). The prediagno… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
67
1
3

Year Published

2009
2009
2021
2021

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 71 publications
(84 citation statements)
references
References 24 publications
7
67
1
3
Order By: Relevance
“…Finally, we found the same demographic and clinical characteristics as in other series of medulloblastomas in children [2,17,33]. Other studies have reported a median prediagnostic interval of 5 (Switzerland) [25], 8 (North America) [17,30], and 22 weeks (India) [27]. The median interval observed in our study (9 weeks) is close to that observed in North America.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Finally, we found the same demographic and clinical characteristics as in other series of medulloblastomas in children [2,17,33]. Other studies have reported a median prediagnostic interval of 5 (Switzerland) [25], 8 (North America) [17,30], and 22 weeks (India) [27]. The median interval observed in our study (9 weeks) is close to that observed in North America.…”
Section: Discussionsupporting
confidence: 92%
“…Existing studies of the time to diagnosis of brain tumours in children and their determinants are of limited value for understanding the specific issues of medulloblastomas, for they group together several types of tumours, different in histology and site [3,8,11,16,25,30,35] and include a fairly small number of medulloblastoma [8,11,16,25,30,35], or are based on recruitment from a single hospital and thus subject to substantial selection bias [8,11,16,17,25,35]. Because the exact causes of diagnosis delays in medulloblastoma in children remain poorly understood, it is difficult to propose guidelines to reduce them [41].…”
Section: Introductionmentioning
confidence: 99%
“…3 This can lead to prediagnostic symptomatic intervals (PSI) ('diagnostic time lags') in the range of several weeks to months. [4][5][6][7][8][9][10][11] The assumption that a longer PSI may result in a more advanced disease stage and/or have an adverse impact on tumor control, survival and/or neurological/neuropsychological/quality of survival outcome may lead to selfreproaches from parents and physicians and can result in accusations of medical malpractice. [12][13][14] However, available information on the correctness of this assumption is insufficient, as studies on PSI in children with brain tumors suffer from low patient numbers, retrospective design, heterogeneity of patient, disease, and treatment characteristics, and lacking outcome data.…”
Section: -2mentioning
confidence: 99%
“…[12][13][14] However, available information on the correctness of this assumption is insufficient, as studies on PSI in children with brain tumors suffer from low patient numbers, retrospective design, heterogeneity of patient, disease, and treatment characteristics, and lacking outcome data. [4][5][6][7][8][9][10][11][15][16][17][18][19][20][21][22][23][24] To study the association of the PSI with disease stage at diagnosis as well as tumor control and survival outcome, we analyzed prospectively collected data on 224 homogeneously treated patients. 3.…”
Section: -2mentioning
confidence: 99%
“…Accordingly, only the length of the prediagnostic symptomatic interval (PSI) can provide some indirect evidence regarding the kinetics of tumour growth: Not only are differences documented between different types of brain tumours, with malignant tumours (e.g. MBs) having shorter PSIs than low-grade tumours [4,10,12,17,19], but considerable variability is seen within the patient group with MB [2,8]: In a large prospective series, we found PSIs ranging from 0 to 24 months, with a median of 2 months. Interestingly, the group of patients with the longest PSIs had lower stage disease at diagnosis and a better overall survival probability than that with shorter PSIs [6].…”
Section: Discussionmentioning
confidence: 99%